Page last updated: 2024-12-06

nagilactone c

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Nagilactone C is a natural product isolated from the leaves of Podocarpus nagi. It exhibits diverse biological activities, including anti-inflammatory, anticancer, and antiviral properties. Nagilactone C has attracted significant research interest due to its potential therapeutic applications. Studies have shown its efficacy in inhibiting the growth of various cancer cell lines, including breast, lung, and colon cancer. Furthermore, nagilactone C has been investigated for its anti-inflammatory effects in models of inflammatory bowel disease. The synthesis of nagilactone C has been achieved through various methods, including a biomimetic approach that mimics the natural biosynthesis pathway. Ongoing research continues to explore the therapeutic potential of nagilactone C and its derivatives.'
```

nagilactone C: norditerpene lactone isolated from leaves of Podocarpus; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID72505
CHEMBL ID487996
MeSH IDM0045659

Synonyms (25)

Synonym
podolactone b, 7, 8-deepoxy-8,14-didehydro-15,16-dideoxy-7-hydroxy-, (7.beta.)-
dihydroxy-isopropyl-dimethyl-[?]dione
nsc117884
nagilactone c
nsc-117884
24338-53-2
nsc-211500
CHEMBL487996
nsc 211500
podolactone b, 7,8-deepoxy-8,14-didehydro-15,16-dideoxy-7-hydroxy-, (1alpha,2alpha,7beta)-
nsc 117884
c19h22o7
(1ar,2r,2ar,4as,4br,5r,9bs,9cs)-2,5-dihydroxy-2a,9b-dimethyl-6-(propan-2-yl)-1a,2,2a,4a,4b,5,9b,9c-octahydro-3h,8h-oxireno[5,6][2]benzofuro[7,1-fg]isochromene-3,8-dione
3J2 ,
FS-8707
DTXSID401019971
(1s,2s,4r,5r,6r,9s,10r,17r)-5,10-dihydroxy-1,6-dimethyl-12-propan-2-yl-3,8,13-trioxapentacyclo[7.7.1.02,4.06,17.011,16]heptadeca-11,15-diene-7,14-dione
nagilactonec
AKOS040762092
CS-0023609
HY-N3215
3h,8h-furo[2',3',4':4,5]oxireno[7,8]naphtho[2,1-c]pyran-3,8-dione, 1a,2,2a,4a,4b,5,9b,9c-octahydro-2,5-dihydroxy-2a,9b-dimethyl-6-(1-methylethyl)-, (1ar,2r,2ar,4as,4br,5r,9bs,9cs)-
3h,8h-furo[2',3',4':4,5]oxireno[7,8]naphtho[2,1-c]pyran-3,8-dione, 1aalpha,2,2a,4abeta,4bbeta,5,9b,9calpha-octahydro-2alpha,5alpha-dihydroxy-6-isopropyl-2abeta,9balpha-dimethyl- (8ci) podolactone b, 7,8-deepoxy-8,14-didehydro-15,16-dideoxy-7-hydroxy-, (1a
38MVA8L9PT
(1ar,2r,2ar,4as,4br,5r,9bs,9cs)-1a,2,2a,4a,4b,5,9b,9c-octahydro-2,5-dihydroxy-2a,9b-dimethyl-6-(1-methylethyl)-3h,8h-furo[2',3',4':4,5]oxireno[7,8]naphtho[2,1-c]pyran-3,8-dione

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" Dose-response experiments in primary cells confirmed pathway selectivity, but importantly also revealed differential inhibition of cell types and new druggability trends across multiple compounds."( High-content single-cell drug screening with phosphospecific flow cytometry.
Clutter, MR; Crane, JM; Krutzik, PO; Nolan, GP, 2008
)
0.35
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (26)

Assay IDTitleYearJournalArticle
AID337835Antifungal activity against Saccharomyces cerevisiae ATCC 7754 after 2 days by broth dilution method1993Journal of natural products, Feb, Volume: 56, Issue:2
Combination effects of antifungal nagilactones against Candida albicans and two other fungi with phenylpropanoids.
AID1378300Cytotoxicity against human HEY cells after 48 hrs by MTT assay2017Journal of natural products, 07-28, Volume: 80, Issue:7
Norditerpenoids and Dinorditerpenoids from the Seeds of Podocarpus nagi as Cytotoxic Agents and Autophagy Inducers.
AID337846Antimicrobial activity against Penicillium chrysogenum ATCC 10106 up to 800 ug/mL after 5 days by broth dilution method1993Journal of natural products, Feb, Volume: 56, Issue:2
Combination effects of antifungal nagilactones against Candida albicans and two other fungi with phenylpropanoids.
AID337834Antifungal activity against Pityrosporum ovale ATCC 14521 at 800 ug/mL after 3 days by broth dilution method1993Journal of natural products, Feb, Volume: 56, Issue:2
Combination effects of antifungal nagilactones against Candida albicans and two other fungi with phenylpropanoids.
AID495065Inhibition of JAK-mediated interferon-gamma-induced Stat1 phosphorylation in human U937 cells by Phospho-Flow cytometry at 20 uM2008Nature chemical biology, Feb, Volume: 4, Issue:2
High-content single-cell drug screening with phosphospecific flow cytometry.
AID332912Antimicrobial activity Propionibacterium acnes ATCC 11827 after 2 days by broth dilution method1994Journal of natural products, Jan, Volume: 57, Issue:1
Naturally occurring antiacne agents.
AID337842Antimicrobial activity against Propionibacterium acnes ATCC 11827 up to 800 ug/mL after 2 days by broth dilution method1993Journal of natural products, Feb, Volume: 56, Issue:2
Combination effects of antifungal nagilactones against Candida albicans and two other fungi with phenylpropanoids.
AID337841Antimicrobial activity against Streptococcus mutans ATCC 25175 up to 800 ug/mL after 2 days by broth dilution method1993Journal of natural products, Feb, Volume: 56, Issue:2
Combination effects of antifungal nagilactones against Candida albicans and two other fungi with phenylpropanoids.
AID337844Antimicrobial activity against Pseudomonas aeruginosa ATCC 10145 up to 800 ug/mL after 2 days by broth dilution method1993Journal of natural products, Feb, Volume: 56, Issue:2
Combination effects of antifungal nagilactones against Candida albicans and two other fungi with phenylpropanoids.
AID1707215Cytotoxicity against human HepG2 cells incubated for 48 hrs by MTT assay2020Journal of medicinal chemistry, 12-24, Volume: 63, Issue:24
Development of Potential Antitumor Agents from the Scaffolds of Plant-Derived Terpenoid Lactones.
AID1707216Cytotoxicity against human Panc-1 cells incubated for 48 hrs by MTT assay2020Journal of medicinal chemistry, 12-24, Volume: 63, Issue:24
Development of Potential Antitumor Agents from the Scaffolds of Plant-Derived Terpenoid Lactones.
AID1707214Cytotoxicity against human HeLa cells incubated for 48 hrs by MTT assay2020Journal of medicinal chemistry, 12-24, Volume: 63, Issue:24
Development of Potential Antitumor Agents from the Scaffolds of Plant-Derived Terpenoid Lactones.
AID1378299Cytotoxicity against human A2780 cells after 48 hrs by MTT assay2017Journal of natural products, 07-28, Volume: 80, Issue:7
Norditerpenoids and Dinorditerpenoids from the Seeds of Podocarpus nagi as Cytotoxic Agents and Autophagy Inducers.
AID337840Antimicrobial activity against Staphylococcus aureus ATCC 12598 up to 800 ug/mL after 2 days by broth dilution method1993Journal of natural products, Feb, Volume: 56, Issue:2
Combination effects of antifungal nagilactones against Candida albicans and two other fungi with phenylpropanoids.
AID495064Inhibition of JAK-mediated GM-CSF-induced Stat5 phosphorylation in human U937 cells by Phospho-Flow cytometry at 20 uM2008Nature chemical biology, Feb, Volume: 4, Issue:2
High-content single-cell drug screening with phosphospecific flow cytometry.
AID335255In vivo antitumor activity against mouse P388 cells at 20 mg/kg relative to control
AID337843Antimicrobial activity against Escherichia coli ATCC 9637 up to 800 ug/mL after 2 days by broth dilution method1993Journal of natural products, Feb, Volume: 56, Issue:2
Combination effects of antifungal nagilactones against Candida albicans and two other fungi with phenylpropanoids.
AID338749Cytotoxicity against mouse P388 cells
AID1707213Cytotoxicity against human AGS cells incubated for 48 hrs by MTT assay2020Journal of medicinal chemistry, 12-24, Volume: 63, Issue:24
Development of Potential Antitumor Agents from the Scaffolds of Plant-Derived Terpenoid Lactones.
AID1707187Cytotoxicity against human MDA-MB-231 cells incubated for 48 hrs by MTT assay2020Journal of medicinal chemistry, 12-24, Volume: 63, Issue:24
Development of Potential Antitumor Agents from the Scaffolds of Plant-Derived Terpenoid Lactones.
AID337839Antimicrobial activity against Brevibacterium ammoniagenes ATCC 6872 up to 800 ug/mL after 2 days by broth dilution method1993Journal of natural products, Feb, Volume: 56, Issue:2
Combination effects of antifungal nagilactones against Candida albicans and two other fungi with phenylpropanoids.
AID495066Inhibition of anisomycin-induced p38 phosphorylation in human U937 cells by Phospho-Flow cytometry at 20 uM2008Nature chemical biology, Feb, Volume: 4, Issue:2
High-content single-cell drug screening with phosphospecific flow cytometry.
AID337837Antifungal activity against Pityrosporum ovale ATCC 14521 after 3 days by broth dilution method1993Journal of natural products, Feb, Volume: 56, Issue:2
Combination effects of antifungal nagilactones against Candida albicans and two other fungi with phenylpropanoids.
AID337847Antifungal activity against Saccharomyces cerevisiae ATCC 7754 at 1600 ug/mL after 2 days by broth dilution method1993Journal of natural products, Feb, Volume: 56, Issue:2
Combination effects of antifungal nagilactones against Candida albicans and two other fungi with phenylpropanoids.
AID337833Antifungal activity against Candida albicans ATCC 18804 at 800 ug/mL after 2 days by broth dilution method1993Journal of natural products, Feb, Volume: 56, Issue:2
Combination effects of antifungal nagilactones against Candida albicans and two other fungi with phenylpropanoids.
AID337845Antimicrobial activity against Enterobacter aerogenes ATCC 13048 up to 800 ug/mL after 2 days by broth dilution method1993Journal of natural products, Feb, Volume: 56, Issue:2
Combination effects of antifungal nagilactones against Candida albicans and two other fungi with phenylpropanoids.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (16)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (12.50)18.7374
1990's2 (12.50)18.2507
2000's4 (25.00)29.6817
2010's6 (37.50)24.3611
2020's2 (12.50)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.92

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.92 (24.57)
Research Supply Index2.94 (2.92)
Research Growth Index4.86 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.92)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (5.56%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other17 (94.44%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]